These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8805943)

  • 1. Purging of peripheral blood progenitor cells.
    Brugger W; Scheding S; Vogel W; Kanz L
    Ann Oncol; 1996; 7 Suppl 2():11-3. PubMed ID: 8805943
    [No Abstract]   [Full Text] [Related]  

  • 2. Ex-vivo purging of hematopoietic progenitor cells.
    de Lima M; Shpall EJ
    Curr Hematol Rep; 2004 Jul; 3(4):257-64. PubMed ID: 15217555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo purging and cell expansion.
    Ball ED
    J Hematother Stem Cell Res; 1999 Oct; 8(5):457-8. PubMed ID: 10791896
    [No Abstract]   [Full Text] [Related]  

  • 4. Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
    Kvalheim G; Wang MY; Pharo A; Holte H; Jacobsen E; Beiske K; Kvaløy S; Smeland E; Funderud S; Fodstad O
    J Hematother; 1996 Aug; 5(4):427-36. PubMed ID: 8877718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of normal progenitor cells from acute myeloid leukemia cell-contaminated CD34+ peripheral blood progenitor cells after mafosfamide purging.
    Stilz R; Grünebach F; Bader P; Vogel W; Kanz L; Brugger W; Scheding S
    J Hematother Stem Cell Res; 2001 Dec; 10(6):777-85. PubMed ID: 11798504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of cytokines on high dose chemotherapy followed by transplantation of purified and ex vivo expanded peripheral blood stem cells: achieving a state of minimal residual disease for tumor immunotherapy with cytokine gene transfected cells.
    Mertelsmann R
    Eur Cytokine Netw; 1995; 6(2):79-82. PubMed ID: 7578991
    [No Abstract]   [Full Text] [Related]  

  • 7. Mononuclear and CD34+ stem cell recovery after automated Ficoll processing of marrow or peripheral blood stem cells for transplantation.
    Cottler-Fox M; Read EJ; Yu M; Carter C; Klein HG
    Prog Clin Biol Res; 1992; 377():569-73. PubMed ID: 1279726
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution study.
    Belhadj K; Delfau-Larue MH; Elgnaoui T; Beaujean F; Beaumont JL; Pautas C; Gaillard I; Kirova Y; Allain A; Gaulard P; Farcet JP; Reyes F; Haioun C
    Ann Oncol; 2004 Mar; 15(3):504-10. PubMed ID: 14998857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methods of mobilizing hematopoietic cells, their collection using cell separation, purging--processing of pathologic cells and enrichment with CD 34+ cells--negative and positive selection].
    Walter Z; Szostek M; Mensah P; Lorenz F; Weglarska D; Skotnicki AB
    Przegl Lek; 1999; 56 Suppl 1():22-7. PubMed ID: 10494178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The CD34 antigen: potential clinical advantages of CD34 selection.
    Holyoake TL; Alcorn MJ; Franklin IM
    Clin Oncol (R Coll Radiol); 1996; 8(4):214-21. PubMed ID: 8870998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cells.
    Purdy MH; Shpall EJ
    Med Oncol; 1994; 11(2):47-51. PubMed ID: 7531586
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral blood stem cells for autografting.
    Shpall EJ; Cagnoni PJ; Bearman SI; Ross M; Jones RB
    Annu Rev Med; 1997; 48():241-51. PubMed ID: 9046959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and positive selection of human progenitor/stem cells for bone marrow transplantation.
    Civin CI
    Prog Clin Biol Res; 1992; 377():461-72; discussion 473. PubMed ID: 1279715
    [No Abstract]   [Full Text] [Related]  

  • 14. The efficiency of tumor cell purging using immunomagnetic CD34+ cell separation systems.
    Roots-Weiss A; Papadimitriou C; Serve H; Hoppe B; Koenigsmann M; Reufi B; Oberberg D; Thiel E; Berdel WE
    Bone Marrow Transplant; 1997 Jun; 19(12):1239-46. PubMed ID: 9208119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of granulocyte colony-stimulating factor in mobilization and transplantation of peripheral blood progenitor and stem cells .
    Haas R; Murea S
    Cytokines Mol Ther; 1995 Dec; 1(4):249-70. PubMed ID: 9384679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous bone marrow support and bone disease in metastatic breast cancer.
    Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
    Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of stem cells enriched by immunoadsorption.
    Berenson RJ; Bensinger WI; Kalamasz DF; Heimfeld S; Goffe RA; Berninger RW; Peterson DR; Thompson P; Strong DM
    Prog Clin Biol Res; 1992; 377():449-57; discussion 458-9. PubMed ID: 1279714
    [No Abstract]   [Full Text] [Related]  

  • 18. CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections.
    Altès A; Sierra J; Esteve J; Martín-Henao G; Marín P; Sureda A; Briones J; Martino R; Villamor N; Colomer D; Carreras E; Garcia J; Brunet S; Montserrat E
    Exp Hematol; 2002 Jul; 30(7):824-30. PubMed ID: 12135682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of CD34 selection and complement-mediated immunopurging (anti-CD15 monoclonal antibody) eliminates tumor cells while sparing normal progenitor cells.
    Nimgaonkar M; Kemp A; Lancia J; Ball ED
    J Hematother; 1996 Feb; 5(1):39-48. PubMed ID: 8646480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial.
    Stewart AK; Vescio R; Schiller G; Ballester O; Noga S; Rugo H; Freytes C; Stadtmauer E; Tarantolo S; Sahebi F; Stiff P; Meharchard J; Schlossman R; Brown R; Tully H; Benyunes M; Jacobs C; Berenson R; White M; DiPersio J; Anderson KC; Berenson J
    J Clin Oncol; 2001 Sep; 19(17):3771-9. PubMed ID: 11533101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.